RSCI (Redwood Scientific Technologies) Market Cap: $2.27 Mil (As of Jul. 10, 2026)


What is Redwood Scientific Technologies Market Cap?

Redwood Scientific Technologies RSCI Market Cap is $2.27 Mil as of Jul. 10, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Redwood Scientific Technologies's share price for the quarter that ended in Dec. 2023 was $0.1111. Redwood Scientific Technologies's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 204.18 Mil. Therefore, Redwood Scientific Technologies's market cap for the quarter that ended in Dec. 2023 was $22.68 Mil.

Redwood Scientific Technologies's quarterly market cap increased from Dec. 2021 ($0.53 Mil) to Dec. 2022 ($1.07 Mil) and increased from Dec. 2022 ($1.07 Mil) to Dec. 2023 ($22.68 Mil).

Redwood Scientific Technologies's annual market cap increased from Dec. 2021 ($0.53 Mil) to Dec. 2022 ($1.07 Mil) and increased from Dec. 2022 ($1.07 Mil) to Dec. 2023 ($22.68 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Redwood Scientific Technologies's Enterprise Value for Today is $2.27 Mil.

Redwood Scientific Technologies  (OTCPK:RSCI) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Redwood Scientific Technologies Market Cap Related Terms

Redwood Scientific Technologies Market Cap Historical Data

* Premium members only.

The historical data trend for Redwood Scientific Technologies's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redwood Scientific Technologies Market Cap Chart

Redwood Scientific Technologies Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Market Cap
8.88 0.53 1.07 22.68

Redwood Scientific Technologies Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Market Cap 8.88 0.53 1.07 22.68

RSCI vs RAPH, FLGC, TXMD: Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Redwood Scientific Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Redwood Scientific Technologies Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Redwood Scientific Technologies's Market Cap distribution charts can be found below:

* The bar in red indicates where Redwood Scientific Technologies's Market Cap falls into.


Redwood Scientific Technologies Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Redwood Scientific Technologies's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=$0.1111*204.177
=$22.68

Redwood Scientific Technologies's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=$0.1111*204.177
=$22.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $2.27 Mil mean?
Redwood Scientific Technologies (RSCI) has a Market Cap of $2.27 Mil as of Jul. 10, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Redwood Scientific Technologies and its competitors.
Is Redwood Scientific Technologies' Market Cap too high?
Redwood Scientific Technologies' current Market Cap is $2.27 Mil. The Drug Manufacturers industry median Market Cap is 214.09. Redwood Scientific Technologies' value of $2.27 Mil is 98.9% below this industry median.
How does Redwood Scientific Technologies' Market Cap compare to RAPH and FLGC?
Redwood Scientific Technologies' Market Cap of $2.27 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 214.09. Redwood Scientific Technologies' value of $2.27 Mil is 98.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 214.09, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Redwood Scientific Technologies's current Market Cap of $2.27 Mil is 98.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Redwood Scientific Technologies and its competitors. For the Drug Manufacturers industry, the median Market Cap is 214.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redwood Scientific Technologies's current Market Cap is $2.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redwood Scientific Technologies stock overvalued right now?
Redwood Scientific Technologies (RSCI) has a current Market Cap of $2.27 Mil. The current Market Cap is $2.27 Mil and 98.9% below the Drug Manufacturers industry median of 214.09. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Redwood Scientific Technologies (RSCI), the current Market Cap is $2.27 Mil as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Redwood Scientific Technologies Business Description

Address 418 Broadway, STE 4872, Albany, NY, USA, 12207
Redwood Scientific Technologies Inc is a pharmaceutical delivery company that develops, operates, and markets over-the-counter products in a sublingual oral thin film strip. RSCI has begun clinical trials on two new products to market for stopping the addiction to nicotine.